recurrent glioblastoma

Houston, Texas, USA, November 5, 2026 ImmunoGenesis, a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies, has announced...

SEONGNAM and SEOUL, South Korea, June 15, 2026 Rznomics Inc., a clinical-stage biopharmaceutical company focused on RNA-based gene therapies,...